Mycoplasma genitalium retrospective audit of Northern Territory isolates from 2022.
| Title: | Mycoplasma genitalium retrospective audit of Northern Territory isolates from 2022. |
|---|---|
| Authors: | Proudmore KE; Advanced Trainee Infectious Diseases and Acute and General Care Medicine, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.; Gunathilake M; Head of Sexual Health & Blood Borne Virus Unit & Senior Staff Specialist, NT Health, Sexual Health Medicine, Public Health Unit (Centre for Disease Control & Environment Health) Rocklands Drive TIWI NT 0810 Australia.; Crawford LC; Clinical Microbiologist and Infectious Diseases Physician, Microbiology & Infectious Diseases Directorate, SA Pathology, Royal Adelaide Hospital; Port Rd, Adelaide SA 5000 Australia.; Freeman K; Supervising Scientist, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.; Menouhos D; Senior Scientist, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.; Baird RW; Clinical Microbiologist and Director of Pathology, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia. |
| Source: | Communicable diseases intelligence (2018) [Commun Dis Intell (2018)] 2024 Aug 21; Vol. 48. Date of Electronic Publication: 2024 Aug 21. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Health Protection Policy Branch, Office of Health Protection, Australian Government Department of Health Country of Publication: Australia NLM ID: 101735394 Publication Model: Electronic Cited Medium: Internet ISSN: 2209-6051 (Electronic) Linking ISSN: 22096051 NLM ISO Abbreviation: Commun Dis Intell (2018) Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Canberra, ACT : Health Protection Policy Branch, Office of Health Protection, Australian Government Department of Health, [2018]- |
| MeSH Terms: | Mycoplasma genitalium*/isolation & purification ; Mycoplasma Infections*/epidemiology ; Mycoplasma Infections*/microbiology; Northern Territory/epidemiology ; Anti-Bacterial Agents/pharmacology ; Sexually Transmitted Diseases/epidemiology ; Sexually Transmitted Diseases/microbiology ; Macrolides/pharmacology ; Humans ; Retrospective Studies ; Prevalence ; Male ; Female ; Adult ; Drug Resistance, Bacterial ; Middle Aged ; Young Adult |
| Abstract: | Abstract: The Northern Territory (NT) has the highest rates of sexually transmitted infections (STI) in Australia; however, the local prevalence of Mycoplasma genitalium (M. genitalium) has not been previously determined. This study was designed to review M. genitalium detection, to determine the regional NT prevalence and macrolide resistance rates. In our study the NT background prevalence of M. genitalium is 13%, with the highest detection rates occurring in central Australia and in correctional facility inmates. Symptomatic patients attending sexual health clinics have a positivity rate of 12%, but very high macrolide resistance. The decision to screen for M. genitalium should be based on several factors, including the prevalence of the infection in the local population; the availability of effective treatments; and the potential benefits and risks of detection and therapy.; (© Commonwealth of Australia CC BY-NC-ND.) |
| Contributed Indexing: | Keywords: Mycoplasma genitalium; Northern Territory; STI; infectious diseases; sexually transmitted disease |
| Substance Nomenclature: | 0 (Anti-Bacterial Agents); 0 (Macrolides) |
| Entry Date(s): | Date Created: 20240821 Date Completed: 20240821 Latest Revision: 20240821 |
| Update Code: | 20260130 |
| DOI: | 10.33321/cdi.2024.48.43 |
| PMID: | 39165019 |
| Database: | MEDLINE |
Journal Article